354 related articles for article (PubMed ID: 1314105)
1. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
2. Antifungal agents. Part II. The azoles.
Terrell CL
Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
[TBL] [Abstract][Full Text] [Related]
3. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
4. Azole antifungal agents: emphasis on new triazoles.
Saag MS; Dismukes WE
Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
[TBL] [Abstract][Full Text] [Related]
5. [Emerging azole antifungals].
Wolff M; Bouadma L; Mourvillier B
Therapie; 2006; 61(3):227-33. PubMed ID: 16989123
[TBL] [Abstract][Full Text] [Related]
6. [Anti-Candida activity of azoles].
Van Cutsem J; Van Gerven F; Janssen PA
Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
[TBL] [Abstract][Full Text] [Related]
7. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
[TBL] [Abstract][Full Text] [Related]
8. Azole antifungal drugs: old and new.
Dismukes WE
Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
[No Abstract] [Full Text] [Related]
9. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of mycoses and new antifungal agents].
Dupont B
Rev Prat; 1989 Sep; 39(19):1688-94. PubMed ID: 2554481
[TBL] [Abstract][Full Text] [Related]
11. New antifungal agents for the systemic mycoses.
Ringel SM
Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic optimisation of oral antifungal therapy.
Schäfer-Korting M
Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
[TBL] [Abstract][Full Text] [Related]
13. Azole antifungals: 35 years of invasive fungal infection management.
Allen D; Wilson D; Drew R; Perfect J
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
15. Azole drug resistance in yeasts.
Johnson EM; Warnock DW
J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
[No Abstract] [Full Text] [Related]
16. Use of azoles for systemic antifungal therapy.
Kauffman CA; Carver PL
Adv Pharmacol; 1997; 39():143-89. PubMed ID: 9160115
[No Abstract] [Full Text] [Related]
17. The triazole antifungal agents: a review of itraconazole and fluconazole.
Bailey EM; Krakovsky DJ; Rybak MJ
Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging azole antifungal agents.
Sheehan DJ; Hitchcock CA; Sibley CM
Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
[TBL] [Abstract][Full Text] [Related]
19. Azoles and AIDS.
Larsen RA
J Infect Dis; 1990 Sep; 162(3):727-30. PubMed ID: 2167339
[TBL] [Abstract][Full Text] [Related]
20. [Importance of the new triazoles in antifungal therapy].
Durmaz B
Mikrobiyol Bul; 1991 Jan; 25(1):118-23. PubMed ID: 1652677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
